Identification of new candidate drugs in myelodysplastic syndromes with splicing factor mutations by transcriptional profiling and connectivity map analysis. [PDF]
Sun T+8 more
europepmc +1 more source
Structure-Activity Relationship Study of Splicing Modulators on Hsh155/SF3B1 through Chemical Synthesis and Yeast Genetics. [PDF]
Beard JP+4 more
europepmc +1 more source
Integrated Immune Landscape Analysis of RNA Splicing Factor-Mutant AML and Higher risk MDS Treated with Azacitidine ± Durvalumab. [PDF]
Bewersdorf JP+14 more
europepmc +1 more source
Functional consequences of SF3B1 mutations in myelodysplastic syndromes with ring sideroblasts
Sabrina Bondu
openalex +1 more source
[Application of the variant allele frequency of myeloid-associated gene mutations in myelodysplastic syndrome]. [PDF]
Shang MY, Su L.
europepmc +1 more source
Long-Term Transfusion Independence with Luspatercept Versus Epoetin Alfa in Erythropoiesis-Stimulating Agent-Naive, Lower-Risk Myelodysplastic Syndromes in the COMMANDS Trial. [PDF]
Garcia-Manero G+15 more
europepmc +1 more source
Artificial intelligence-based Myelodysplastic Syndromes Score, 2022 classifications, and the Molecular International Prognostic Scoring System: a perfect match. [PDF]
Clichet V, Boyer T.
europepmc +1 more source
Association of Specific Gene Mutations with Immunoglobulin Heavy-Chain Variable Region and Chromosomal Alterations in Chronic Lymphocytic Leukemia Patients in India. [PDF]
Mani S, Nathany S, Diwan H, Mehta A.
europepmc +1 more source
Short Report: The Variants in <i>CHEK2</i> in Metastatic Uveal Melanoma. [PDF]
Terai M+6 more
europepmc +1 more source
Prognostic impact of next-generation sequencing on myelodysplastic syndrome: A single-center experience. [PDF]
Bülbül H+5 more
europepmc +1 more source